Gossamer Bio Inc (GOSS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $67.16M
Last updated: Nov 17, 2026 at 4:10 PM ET
Gossamer Bio Inc (GOSS) Stock Chart
Gossamer Bio (GOSS) has a latest price of $11.04 on Nov 17, 2026, 96.4% below its 52-week high of $309.60. Its price fell 94.9% over the past 12 months. The month-end price fell 99.0% over the 5 years through Oct 2026, a compound annual decline of 59.8%.
Price Chart
From Feb 2019 to Oct 2026, its highest month-end close was $2,040.00 in Nov 2019 and its lowest $10.38 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GOSS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GOSS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.9%, and over 6 months it fell 30.7%. The month-end price fell 74.1% over the 3 years through Oct 2026, a compound annual decline of 36.2%.
| Period | Change |
|---|---|
| 1 month | +31.0% |
| 3 months | -11.9% |
| 6 months | -30.7% |
| 12 months | -94.9% |
| 12 months, with dividends | -94.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -74.1% | -36.2% |
| 5 years | -99.0% | -59.8% |
Price by Year
Its best calendar year was 2025, when the price rose 242.7%, and its weakest was 2022, when it fell 80.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.38 | -95.8% |
| 2025 | $248.00 | +242.7% |
| 2024 | $72.37 | -0.9% |
| 2023 | $73.00 | -57.9% |
| 2022 | $173.60 | -80.8% |
| 2021 | $904.80 | +17.0% |
| 2020 | $773.60 | -38.1% |
Trading Range
The price is 5.8% above its 50-day average of $10.43 and 62.5% below its 200-day average of $29.44.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $11.04 | |
| 52-week high | $309.60 | -96.4% |
| 52-week low | $8.29 | +33.2% |
| 50-day average | $10.43 | +5.8% |
| 200-day average | $29.44 | -62.5% |
Price Risk
Over 3 years, its largest fall from a peak was 97.2%.
| Measure | Value |
|---|---|
| 1-year beta | 2.55 |
| Largest fall, 1 year | -97.2% |
| Largest fall, 3 years | -97.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GOSS
What is GOSS's 1-year price change?
Gossamer Bio's price fell 94.9% over the past 12 months. With dividends included, the 12-month total return was -94.9%.
What is GOSS's 5-year price change?
Gossamer Bio's month-end price fell 99.0% over the 5 years through Oct 2026, a compound annual decline of 59.8%. These figures leave out dividends.
What is GOSS's 52-week high and low?
Gossamer Bio's 52-week high is $309.60 and its 52-week low is $8.29. Its latest price of $11.04 on Nov 17, 2026 is 96.4% below the high.
What is GOSS's beta?
Gossamer Bio's 1-year beta against the S&P 500 is 2.55, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 97.2%.
Is the GOSS chart free?
Yes. Advanced Charting for GOSS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GOSS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors